RNA-mediated toxicity in neurodegenerative disease

被引:63
|
作者
Belzil, Veronique V. [1 ]
Gendron, Tania F. [1 ]
Petrucelli, Leonard [1 ]
机构
[1] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA
基金
美国国家卫生研究院; 加拿大健康研究院;
关键词
RNA processing; Bidirectional transcription; RAN translation; RNA foci; Neurodegenerative diseases; Mouse models; AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; SPINAL MUSCULAR-ATROPHY; HEXANUCLEOTIDE REPEAT EXPANSION; MYOTONIC-DYSTROPHY TYPE-1; BINDING-PROTEIN CUGBP1; ATAXIA TYPE 8; SPINOCEREBELLAR ATAXIA; TRINUCLEOTIDE REPEAT; TRIPLET REPEAT;
D O I
10.1016/j.mcn.2012.12.006
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cellular viability depends upon the well-orchestrated functions carried out by numerous protein-coding and non-coding RNAs, as well as RNA-binding proteins. During the last decade, it has become increasingly evident that abnormalities in RNA processing represent a common feature among many neurodegenerative diseases. In "RNAopathies", which include diseases caused by non-coding repeat expansions, RNAs exert toxicity via diverse mechanisms: RNA foci formation, bidirectional transcription, and the production of toxic RNAs and proteins by repeat associated non-ATG translation. The mechanisms of toxicity in "RNA-binding proteinopathies", diseases in which RNA-binding proteins like TDP-43 and FUS play a prominent role, have yet to be fully elucidated. Nonetheless, both loss of function of the RNA binding protein, and a toxic gain of function resulting from its aggregation, are thought to be involved in disease pathogenesis. As part of the special issue on RNA and Splicing Regulation in Neurodegeneration, this review intends to explore the diverse RNA-related mechanisms contributing to neurodegeneration, with a special emphasis on findings emerging from animal models. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:406 / 419
页数:14
相关论文
共 50 条
  • [1] RNA-Mediated Disease Mechanisms in Neurodegenerative Disorders
    Neueder, Andreas
    JOURNAL OF MOLECULAR BIOLOGY, 2019, 431 (09) : 1780 - 1791
  • [2] RNA-mediated disease
    Swanson, Maurice
    Tuttle, D. L.
    Yuan, Y.
    Poulos, M. G.
    O'Rourke, J.
    Shin, J.
    Charizanis, K.
    Swanson, M. S.
    JOURNAL OF MEDICAL GENETICS, 2007, 44 : S23 - S23
  • [3] Mechanisms of RNA-mediated Disease
    O'Rourke, Jason R.
    Swanson, Maurice S.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (12) : 7419 - 7423
  • [4] Roles of the nucleolus in the CAG RNA-mediated toxicity
    Tsoi, Ho
    Chan, Ho Yin Edwin
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2014, 1842 (06): : 779 - 784
  • [5] Unstable microsatellites and RNA-mediated disease
    不详
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2005, 22 (06): : 867 - 868
  • [6] Huntingtin and Its Role in Mechanisms of RNA-Mediated Toxicity
    Heinz, Annika
    Nabariya, Deepti Kailash
    Krauss, Sybille
    TOXINS, 2021, 13 (07)
  • [7] Myotonic dystrophy: RNA-mediated muscle disease
    Wheeler, Thurman M.
    Thornton, Charles A.
    CURRENT OPINION IN NEUROLOGY, 2007, 20 (05) : 572 - 576
  • [8] RNA-MEDIATED INTERACTIONS
    Kessens, Ryan
    Kumar, Arun
    Ramachandran, Sowmya
    Roberts, Robyn
    MOLECULAR PLANT-MICROBE INTERACTIONS, 2016, 29 (12) : S14 - S14
  • [9] From paramutation to human disease: RNA-mediated heredity
    Rassoulzadegan, Minoo
    Cuzin, Francois
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2015, 44 : 47 - 50
  • [10] RNA-mediated regulation of heterochromatin
    Johnson, Whitney L.
    Straight, Aaron F.
    CURRENT OPINION IN CELL BIOLOGY, 2017, 46 : 102 - 109